Navigation Links
Stronger Doses Fewer Administration for Breast Cancer

According to a research it was found that radiotherapy given in large dosage but in small amounts is very effective against breast cancer//. The researchers from UK and US said that 13 larger doses were found to be effective in the recurrence of cancer when compared to the conventional regime of 25 small doses. The findings were as a result of the 10-year trial which was funded by the Cancer Research UK. They analysed 1,410 women and published their results in the journal Lancet Oncology. The research team consists of the Royal Marsden NHS Foundation Trust, the Gloucestershire Oncology Centre, The Institute of Cancer Research and the University of Wisconsin.

All the 1,410 women who participated in the study had a lumpectomy following treatment for early breast cancer followed by different radiotherapy treatments. The participants were divided into three groups. First group was given the standard treatment of 25 doses of radiation which amounts to 50 grays for a time period of five weeks. The second and the third groups were given 13 doses in the same time period but on received about 39 grays, and the other 42.9 grays. In the first group the risk of recurrence of breast cancer returning was 12.1%. In the group that received 39 grays it was 14.8%, and in the last it was 9.6%. The lead researcher Professor John Yarnold said that further research is necessary before confirming the strategy is more effective than the standard treatment in the long term.


'"/>




Page: 1

Related medicine news :

1. Stronger Backing for Drug-Coated Stents
2. Health Care Ties To Get Stronger Between India And Britain
3. Women Portray Stronger Immune Response As Compared to Men, Study Suggests
4. Stronger Quadricep Controls Knee Osteoarthritis
5. India To Procure 1 Million Doses Of Tamiflu
6. Small Doses Of Radiation Can Help Certain Lung Cancer Patients
7. Polyphenols in Green Tea Cause Liver Damage At High Doses
8. Pre-eclampsia Pronounced With Intake of Vitamins in Large Doses
9. High Doses Of Common Pain killers Can Double The Chances Of Heart attack
10. Even Normal Doses Of Tylenol Could Damage Liver
11. Allergic Individuals Should Carry Two Doses Of EpiPen Says Quebec Coroner
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/27/2017)... Arlington, VA (PRWEB) , ... March 27, 2017 ... ... version 3.0 was transitioned to the OSEHRA popHealth Community in 2014. ... Steering Work Group and the Developer Open Source Project Group. OSEHRA Organizational Member ...
(Date:3/27/2017)... ... March 27, 2017 , ... ... the CE Certificate of Conformity for the Smart System® 20/20. CE Certification builds ... highest industry standards and specifications such as ANSI, ISO and proven test methods ...
(Date:3/27/2017)... ... March 27, 2017 , ... ... training, today announced the launch of a new research study, The Business Readiness ... needed to execute that strategy, and the actual success of achieving individual and ...
(Date:3/27/2017)... CA (PRWEB) , ... March 27, 2017 , ... According ... with prostate cancer, including all stages, is more than 95%. Once the cancer spreads ... to less than 30%. To find out how to avoid this latter group, tune ...
(Date:3/27/2017)... ... March 27, 2017 , ... Golden Triangle Emergency ... on Monday, April 3rd to commemorate the two-year anniversary of the facility. The ... to celebrate two great years while also familiarizing themselves with the facility. , ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... 2017   Pulmatrix, Inc . (NASDAQ: PULM), a clinical ... pulmonary diseases, today announced that it has added two experts ... asthma to its Scientific Advisory Board . ... B. Moss , MD, former chief of the Pediatric Pulmonary ... Center at Stanford University, and David ...
(Date:3/27/2017)... YORK , March 27, 2017 ... colors as the NASDAQ Composite closed the trading session ... lower; and the S&P 500 was down 0.08%. US ... nine sectors finishing the day in green. Pre-market today, ... Wright Medical Group N.V. (NASDAQ: WMGI), Amedica Corporation (NASDAQ: ...
(Date:3/27/2017)... 2017  Impax Laboratories, Inc. (NASDAQ: IPXL)today announced that ... Bisaro as Impax,s President and Chief Executive Officer ... 27, 2017. Mr. Bisaro will succeed J. Kevin ... Chief Executive Officer since December of 2016. ... experience, Mr. Bisaro, 56, is an accomplished global business ...
Breaking Medicine Technology: